tiprankstipranks
Travere Therapeutics (TVTX)
NASDAQ:TVTX
US Market
TVTX
Travere Therapeutics
RESEARCH TOOLSreports
Want to see TVTX full AI Analyst Report?

Travere Therapeutics (TVTX) Income Statement

611 Followers

Travere Therapeutics Income Statement

Last quarter (Q4 2025), Travere Therapeutics's total revenue was $129.69M, an increase of 73.41% from the same quarter last year. In Q4, Travere Therapeutics's net income was $-21.99M. See Travere Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 490.73M$ 233.18M$ 145.24M$ 109.46M$ 131.84M
Gross Profit
$ 419.65M$ 225.43M$ 133.79M$ 105.04M$ 128.02M
Operating Expenses
$ 482.47M$ 549.26M$ 521.93M$ 424.85M$ 327.44M
Depreciation and Amortization
$ 60.74M$ 43.55M$ 38.53M$ 20.72M$ 12.75M
EBITDA
$ 22.22M$ -265.77M$ -326.25M$ -299.42M$ -184.46M
Operating Income
$ -62.82M$ -323.83M$ -388.14M$ -319.81M$ -199.43M
Other Income/Expenses
$ 13.55M$ 3.32M$ 12.03M$ -11.34M$ -17.46M
Pretax Income
$ -49.27M$ -320.51M$ -376.11M$ -331.15M$ -216.88M
Net Income
$ -50.26M$ -321.55M$ -111.40M$ -278.48M$ -180.09M
Per Share Metrics
Basic EPS
$ -0.56$ -4.08$ -1.50$ -4.37$ -3.01
Diluted EPS
$ -0.56$ -4.08$ -1.50$ -4.37$ -3.01
Weighted Average Shares Outstanding
 89.21M 78.89M 74.27M 63.76M 59.83M
Weighted Average Shares Outstanding (Diluted)
 89.21M 78.89M 74.27M 63.76M 59.83M
Currency in USD

Travere Therapeutics Earnings and Revenue History